The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
In compliance with applicable State regulatory authorities, COVID-19 vaccination is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical or fully remote exemption. Requests for medical exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
*Staff working at a MSK New Jersey location must be up to date with COVID-19 vaccination, which includes having completed the primary COVID-19 vaccination series and booster once eligible as mandated by New Jersey State. All New Jersey staff not yet eligible for a booster must receive a booster within 3 weeks of becoming eligible as a condition of continued employment at MSK.
Note: Individuals are eligible to receive a COVID-19 booster two months after completion of a primary vaccination series for COVID-19. Because vaccine-induced immunity can wane over time, MSK continues to strongly urge all staff to get a COVID-19 booster as soon as they become eligible to maintain their protective immunity for a longer period.
The Department of Pathology at MSK is a dedicated, diverse group known for their expertise, resourcefulness, and compassion! Working in a highly motivating environment, the group receives a sophisticated variety of more than 110,000 specimens annually. We also perform more than 50,000 molecular diagnostic tests.
We have more than 600 staff members are spread across four laboratory services: surgical pathology, hematopathology, cytology, and molecular diagnostics. Pathology provides laboratory support for the Mohs micrographic and dermatologic surgery program and supports MSK’s research mission through the division of experimental pathology. We’re also advancing the field of digital pathology through our slide scanning and computational pathology efforts. All of our laboratories are equipped with innovative equipment, such as ThermoFisher senior grossing stations with sophisticated camera optics and touch screens, laser capture microdissection capabilities, telecytology remote microscopy, advanced flow cytometry panels, and Illumina sequencing instruments.
We are currently seeking a full-time Histotechnologist to join our team!
Learn more about our Benefits!
Pay Range $36.88-$57.13
Please click to learn more about MSK’s compensation philosophy.
***$5,000 sign-on bonus | Open to new employees only
As one of the world's premier cancer centers, Memorial Sloan Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs.
The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover ...